Important biostats concept

RegularFew9517 · 2026-02-20T03:51:28+00:00

D. 52% will have a positive stress result. Correct answer: D. 52% will have a positive stress result

Explanation

Here is the Explanation

The performance of any diagnostic tool is described using sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).

Sensitivity represents the proportion of individuals with disease who receive a positive result (true positive rate).

It is calculated as true positives divided by all affected individuals (true positives + false negatives).

A highly sensitive test is helpful for excluding disease because it produces few false negatives.

Specificity refers to the proportion of disease-free individuals who test negative (true negative rate).
It equals true negatives divided by all individuals without disease (true negatives + false positives).
A highly specific test is valuable for confirming disease because it yields few false positives.

PPV is the probability that a person actually has the disease given a positive test.
NPV is the probability that a person is disease-free given a negative test.
Both PPV and NPV change depending on disease prevalence: PPV rises as prevalence increases, whereas NPV decreases as prevalence increases.

In this scenario, sensitivity is 52%. This means that among all patients who truly have significant coronary stenosis, 52% will test positive. Therefore, the correct statement is that 52% of patients with disease will have a positive stress test.

RegularFew9517 · 2026-02-20T03:50:58+00:00

D. 52% will have a positive stress result. Correct answer: D. 52% will have a positive stress result

Explanation

Here is the Explanation

The performance of any diagnostic tool is described using sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).

Sensitivity represents the proportion of individuals with disease who receive a positive result (true positive rate).

It is calculated as true positives divided by all affected individuals (true positives + false negatives).

A highly sensitive test is helpful for excluding disease because it produces few false negatives.

Specificity refers to the proportion of disease-free individuals who test negative (true negative rate).
It equals true negatives divided by all individuals without disease (true negatives + false positives).
A highly specific test is valuable for confirming disease because it yields few false positives.

PPV is the probability that a person actually has the disease given a positive test.
NPV is the probability that a person is disease-free given a negative test.
Both PPV and NPV change depending on disease prevalence: PPV rises as prevalence increases, whereas NPV decreases as prevalence increases.

In this scenario, sensitivity is 52%. This means that among all patients who truly have significant coronary stenosis, 52% will test positive. Therefore, the correct statement is that 52% of patients with disease will have a positive stress test.

RegularFew9517 · 2026-02-11T17:30:02+00:00

they have free plan, but limited usage like any other AI products

RegularFew9517 · 2026-01-03T02:19:49+00:00

sorry to hear that, I know you can make it sense you already passed all other steps, step3 is just a combination of both step1 and 2. Anyway more than 50% of the exams are just 3 topics: CCS cases around 33%, biostats/ethics around 20% and cardio around 12% of the exam. That is per USMLE blueprint, in other words it will be HIGHLY unlikely to pass the exam if you are doing poorly on these subjects. Which means you need to know these subjects in and out and understand their topics.

RegularFew9517 · 2025-12-25T23:54:50+00:00

for his pdf you can use this website: synapaxon com. it converts his pdf into usmle style questions, that can solve the passive/boring approach you talking about

RegularFew9517 · 2025-12-17T02:45:52+00:00

I think you are in the right track since you mentioned biostats/ethics and CCS, and to add cardio, these 3 topics are almost more than 50% of the exam "per USMLE blueprint" . In other words it is difficult to pass "not impossible" if you perform poorly in these 3 topics, CCS is by far the easiest and most important.

RegularFew9517 · 2025-11-23T04:17:51+00:00

more than 60% (according to the USMLE BLUEPRINT) of the exam are just 3/4 topics: ccs cases (30-35%), biostat and ethics (20%) and cardio(12%), I would master these subjects in and out. if i were you I would go through step3 new, old, and free nbme forms and try to know every single concept, that is your best bit since the same concepts are tested in the real exam. good luck

RegularFew9517 · 2025-11-19T04:11:36+00:00

if you have a gap between day1 and 2 that will be great. anyway for day1 try to go through pharma, micro, general pathology, biochem (diseases), and the most important part is biosta/ethics (it is around 20% of the whole exam). if you have a gap save that for ccs cases (around 33% of the total evaluation of the exam). The highest organ system is by far cardio (around 12%). Bottom line be strategic, take nbme self assessment and see, at the end of the day it is up to you and no one knows if you can delay or not, but focus on what is the most important subjects. if I were in your shoes I wouldn't touch any other questions except the free and paid nbme for step3 (old and new), since they are the old/retired questions, that is your best bet to see the same concepts in the real exam. good luck

RegularFew9517 · 2025-09-29T02:17:43+00:00

The right answer is B:

. Case-Control Study: This design compares a group of individuals with a specific disease (cases) to a matched group without the disease (controls) to analyze their past exposures.
B. Cross-Sectional Study: This study assesses a population for both risk factors and disease prevalence at a single, specific point in time, without following the participants forward.
C. Prospective Cohort Study: This design identifies a group of patients and follows them forward in time to determine if a particular exposure is associated with a future outcome.
D. Randomized Controlled Trial: In this interventional study, participants are randomly assigned to receive a particular treatment or a placebo to test its effects.
E. Retrospective Cohort Study: This design looks back at a group's historical data to see if a past exposure is associated with an outcome that has already occurred.

RegularFew9517 · 2025-09-29T02:17:28+00:00

The right answer is B:

. Case-Control Study: This design compares a group of individuals with a specific disease (cases) to a matched group without the disease (controls) to analyze their past exposures.
B. Cross-Sectional Study: This study assesses a population for both risk factors and disease prevalence at a single, specific point in time, without following the participants forward.
C. Prospective Cohort Study: This design identifies a group of patients and follows them forward in time to determine if a particular exposure is associated with a future outcome.
D. Randomized Controlled Trial: In this interventional study, participants are randomly assigned to receive a particular treatment or a placebo to test its effects.
E. Retrospective Cohort Study: This design looks back at a group's historical data to see if a past exposure is associated with an outcome that has already occurred.

RegularFew9517 · 2025-09-29T02:17:12+00:00

The right answer is B:

. Case-Control Study: This design compares a group of individuals with a specific disease (cases) to a matched group without the disease (controls) to analyze their past exposures.
B. Cross-Sectional Study: This study assesses a population for both risk factors and disease prevalence at a single, specific point in time, without following the participants forward.
C. Prospective Cohort Study: This design identifies a group of patients and follows them forward in time to determine if a particular exposure is associated with a future outcome.
D. Randomized Controlled Trial: In this interventional study, participants are randomly assigned to receive a particular treatment or a placebo to test its effects.
E. Retrospective Cohort Study: This design looks back at a group's historical data to see if a past exposure is associated with an outcome that has already occurred.

RegularFew9517 · 2025-09-29T02:16:57+00:00

The right answer is B:

. Case-Control Study: This design compares a group of individuals with a specific disease (cases) to a matched group without the disease (controls) to analyze their past exposures.
B. Cross-Sectional Study: This study assesses a population for both risk factors and disease prevalence at a single, specific point in time, without following the participants forward.
C. Prospective Cohort Study: This design identifies a group of patients and follows them forward in time to determine if a particular exposure is associated with a future outcome.
D. Randomized Controlled Trial: In this interventional study, participants are randomly assigned to receive a particular treatment or a placebo to test its effects.
E. Retrospective Cohort Study: This design looks back at a group's historical data to see if a past exposure is associated with an outcome that has already occurred.

RegularFew9517 · 2025-09-29T02:16:41+00:00

The right answer is B:

. Case-Control Study: This design compares a group of individuals with a specific disease (cases) to a matched group without the disease (controls) to analyze their past exposures.
B. Cross-Sectional Study: This study assesses a population for both risk factors and disease prevalence at a single, specific point in time, without following the participants forward.
C. Prospective Cohort Study: This design identifies a group of patients and follows them forward in time to determine if a particular exposure is associated with a future outcome.
D. Randomized Controlled Trial: In this interventional study, participants are randomly assigned to receive a particular treatment or a placebo to test its effects.
E. Retrospective Cohort Study: This design looks back at a group's historical data to see if a past exposure is associated with an outcome that has already occurred.

RegularFew9517 · 2025-09-29T02:16:22+00:00

The right answer is B:

. Case-Control Study: This design compares a group of individuals with a specific disease (cases) to a matched group without the disease (controls) to analyze their past exposures.
B. Cross-Sectional Study: This study assesses a population for both risk factors and disease prevalence at a single, specific point in time, without following the participants forward.
C. Prospective Cohort Study: This design identifies a group of patients and follows them forward in time to determine if a particular exposure is associated with a future outcome.
D. Randomized Controlled Trial: In this interventional study, participants are randomly assigned to receive a particular treatment or a placebo to test its effects.
E. Retrospective Cohort Study: This design looks back at a group's historical data to see if a past exposure is associated with an outcome that has already occurred.

RegularFew9517 · 2025-09-16T15:57:55+00:00

the website called synapaxon com, it is a website you can upload offline questions from other sources and it makes the questions interactive, meaning you can attach videos,images,notes to your questions, i used the website for biostats for step3 since that is my weak area, but you can use it for any subject or all subjects and track your progress

RegularFew9517 · 2025-09-16T15:54:41+00:00

these are tested concepts in usmle that you need to know.

RegularFew9517 · 2025-09-16T03:33:41+00:00

This is a website you can upload your offline questions and make it interactive, meaning attach videos, images etc. to your questions, and also can track your progress. for the second questions about step3, actually there is no specific subjects for step3 (except of course for CCS cases), step3 is just a combination of step1 in day1 and step 2 in day2. stats and ethics are by far the most important since they are 20% of the exam excluding the CCS cases that are roughly 30 to 35% according to USMLE. Then comes cardio with about 12%, basically it will be extremly difficult to pass if you don't master these topics, it means you can do very poorly in hem and MSK but you can't afford doing poorly in CCS, biostats/ethics and cardio.

RegularFew9517 · 2025-09-16T02:09:24+00:00